150 related articles for article (PubMed ID: 29222269)
21. Central nervous system and head and neck imaging findings of MYC/BCL2 "double hit" B cell lymphoma.
Khaleel ZL; Wright MP; Quigley E; Singh TJ; Jones R
J Clin Neurosci; 2014 Feb; 21(2):326-7. PubMed ID: 23932423
[TBL] [Abstract][Full Text] [Related]
22. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
[TBL] [Abstract][Full Text] [Related]
23. Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics.
Turakhia SK; Hill BT; Dufresne SD; Nakashima MO; Cotta CV
Am J Clin Pathol; 2014 Sep; 142(3):339-46. PubMed ID: 25125624
[TBL] [Abstract][Full Text] [Related]
24. A clinician's guide to double hit lymphomas.
Cheah CY; Oki Y; Westin JR; Turturro F
Br J Haematol; 2015 Mar; 168(6):784-95. PubMed ID: 25529575
[TBL] [Abstract][Full Text] [Related]
25. MYC/BCL2 double-hit high-grade B-cell lymphoma.
Li S; Lin P; Young KH; Kanagal-Shamanna R; Yin CC; Medeiros LJ
Adv Anat Pathol; 2013 Sep; 20(5):315-26. PubMed ID: 23939148
[TBL] [Abstract][Full Text] [Related]
26. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups.
Ozsan N; Bedke BJ; Law ME; Inwards DJ; Ketterling RP; Knudson RA; Keeney GL; Dogan A; Feldman AL
Am J Surg Pathol; 2011 Nov; 35(11):1691-9. PubMed ID: 21997689
[TBL] [Abstract][Full Text] [Related]
28. Primary ovarian Burkitt lymphoma: report of a case and review of literature.
Xu H; Zhao C; Wang Q; Chen Y; Zhang W; Zhuang Y; Chen R; Zhang H
Int J Clin Exp Pathol; 2022; 15(3):110-119. PubMed ID: 35414839
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH
Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234
[TBL] [Abstract][Full Text] [Related]
30. The prognosis of
Clipson A; Barrans S; Zeng N; Crouch S; Grigoropoulos NF; Liu H; Kocialkowski S; Wang M; Huang Y; Worrillow L; Goodlad J; Buxton J; Neat M; Fields P; Wilkins B; Grant JW; Wright P; Ei-Daly H; Follows GA; Roman E; Watkins AJ; Johnson PW; Jack A; Du MQ
J Pathol Clin Res; 2015 Jul; 1(3):125-133. PubMed ID: 27347428
[TBL] [Abstract][Full Text] [Related]
31. Primary Mediastinal Large B-Cell Lymphoma With Translocations Involving BCL6 and MYC (Double-Hit Lymphoma).
Campuzano-Zuluaga G; Ortiz D; Peng JH; Francis Ikpatt O; Fan YS; Barredo JC; Vega F; Chapman JR
Am J Clin Pathol; 2016 May; 145(5):710-6. PubMed ID: 27124935
[TBL] [Abstract][Full Text] [Related]
32. Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.
Pedersen MØ; Gang AO; Brown P; Pedersen M; Knudsen H; Nielsen SL; Poulsen T; Wirenfeldt Klausen T; Høgdall E; Nørgaard P
PLoS One; 2017; 12(10):e0186983. PubMed ID: 29088292
[TBL] [Abstract][Full Text] [Related]
33. Primary diffuse large B-cell lymphoma of the ovary is of a germinal centre B-cell-like phenotype.
Sun J; Zhang J; Ling Q; Luo Y; Wu S; Liang Z; Zhong D; Zeng X
Virchows Arch; 2015 Jan; 466(1):93-100. PubMed ID: 25403088
[TBL] [Abstract][Full Text] [Related]
34. Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).
da Cunha Santos G; Ko HM; Saieg MA; Boerner SL; Lai SW; Bailey D; Geddie WR
Cancer Cytopathol; 2011 Aug; 119(4):254-62. PubMed ID: 21560251
[TBL] [Abstract][Full Text] [Related]
35. Ovarian Burkitt's lymphoma diagnosed by a combination of clinical features, morphology, immunophenotype, and molecular findings and successfully managed with surgery and chemotherapy.
Chishima F; Hayakawa S; Ohta Y; Sugita K; Yamazaki T; Sugitani M; Yamamoto T
Int J Gynecol Cancer; 2006; 16 Suppl 1():337-43. PubMed ID: 16515618
[TBL] [Abstract][Full Text] [Related]
36. "Double-Hit" mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression.
Wu D; Wood BL; Dorer R; Fromm JR
Am J Clin Pathol; 2010 Aug; 134(2):258-65. PubMed ID: 20660329
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
Akyurek N; Uner A; Benekli M; Barista I
Cancer; 2012 Sep; 118(17):4173-83. PubMed ID: 22213394
[TBL] [Abstract][Full Text] [Related]
38. [Clinical features in DLBCL and translocation BCL2/c-MYC "double hit" lymphoma].
Škunca Ž; Domimis M; Plninc-Peraica A; Jakšić B
Acta Med Croatica; 2014 Jun; 68(3):299-305. PubMed ID: 26016222
[TBL] [Abstract][Full Text] [Related]
39. Double-hit lymphoma (rearrangements of MYC, BCL-2) during pregnancy: A case report.
Xie F; Zhang LH; Yue YQ; Gu LL; Wu F
World J Clin Cases; 2021 Jan; 9(2):482-488. PubMed ID: 33521119
[TBL] [Abstract][Full Text] [Related]
40. Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma.
Motlló C; Grau J; Juncà J; Ruiz N; Mate JL; Orna E; Navarro JT; Vives S; Sancho JM; Esteban D; Granada I; Feliu E; Ribera JM; Millá F
Cancer Genet Cytogenet; 2010 Dec; 203(2):328-32. PubMed ID: 21156254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
